FEB 08, 2016 9:55 AM PST

Could a Blood Pressure Drug Help Children With Autism?

Autism is a neurodevelopmental disorder, which impairs communication and social interaction skills. The CDC reports that the disorder is on the rise, showing a 30% increase in the number of cases. While the debate has raged over whether or not the increase is due to actual new cases or better diagnostics, and research has focused on causes more than treatments, there might be new information from a study out of the University of Missouri.
A new study looked blood pressure medication for autism

The study conducted there looked at the blood pressure drug propranolol. David Beversdorf, MD, associate professor in the departments of radiology, neurology and psychological sciences at MU and the MU Thompson Center for Autism and Neurodevelopmental Disorders was the senior author of the study. In a press release  from MU he said,  “Propranolol was first reported to improve the language and sociability skills of individuals with autism in 1987, but it was not a randomized, controlled trial, and there has been little follow-up research on this drug in relation to autism. While its intended use is to treat high blood pressure, propranolol has been used off-label to treat performance anxiety for several years. However, this is the first study to show that a single dose of propranolol can improve the conversational reciprocity skills of individuals with autism.”
 
The study participants were 20 individuals with autism who were identified as patients at the MU Thompson Center. One group was given a 40 mg dose of the drug per day and the control group was given a placebo.
 
The study was double blind so patients did not know which pill they had received and neither did the researchers.  About an hour after administration, the researchers had a structured conversation with the participants, each time keeping the topic and intellectual level the same. The MU scientists scored the performance of each participant on six  social skills that were needed to maintain a two way conversation: staying on topic, sharing information, reciprocity or shared conversation, transitions or interruptions, nonverbal communication and maintaining eye contact. When the scores were tallied, the group that had received the medication did significantly better than those who had only received the placebo ()
 
Dr. Beversdorf stressed that this study was small and there needs to be more research on the effects after more than one dose, as well clinical trials to determine which patients might benefit the most of the medication. The study, “Effects of Propranolol on Conversational Reciprocity in Autism Spectrum Disorder: A Pilot, Double-blind, Single-dose Psychopharmacological Challenge Study,” was published in the journal Psychopharmacology. Check out the video below to learn more about autism spectrum disorders and how those on the spectrum manage their daily lives communicating with others and holding conversations.
 
 
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
AUG 28, 2020
Genetics & Genomics
'Jumping' Genes Can Regulate Gene Expression in Human Neurons
AUG 28, 2020
'Jumping' Genes Can Regulate Gene Expression in Human Neurons
Even though genes that code for protein have been an intense focus of biomedical research for decades, the human genome ...
SEP 03, 2020
Health & Medicine
High BMI and Waist Circumference Increase Dementia Risk
SEP 03, 2020
High BMI and Waist Circumference Increase Dementia Risk
New research from University College London (UCL) provides another link between obesity and dementia risk. The study cit ...
OCT 03, 2020
Clinical & Molecular DX
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
OCT 03, 2020
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
Researchers at Harvard have discovered a novel diagnostic marker of dementia for identifying undiagnosed patients or tho ...
OCT 14, 2020
Neuroscience
Researchers Pinpoint Neurons Affected by Epilepsy
OCT 14, 2020
Researchers Pinpoint Neurons Affected by Epilepsy
Video: Explains in more detail the different receptors affected by epilepsy. Researchers at the University of Copenhagen ...
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 18, 2020
Clinical & Molecular DX
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
NOV 18, 2020
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disor ...
Loading Comments...